Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-β, IL-10 and Ki67

(2010) Elin Richardsen et al.   Cancer Epidemiology

Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward

(2010) D. G. Menter et al.   CLINICAL CANCER RESEARCH

Prostaglandins promote osteoclastlike cell formation by a mechanism involving cyclic adenosine 3′,5′-monophosphate in mouse bone marrow cell cultures

(2010) Takuhiko Akatsu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Development and characterization of a conditionally immortalized human fetal osteoblastic cell line

(2010) Steven A. Harris et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Glucosamine inhibits IL-1β-mediated IL-8 production in prostate cancer cells by MAPK attenuation

(2009) Cheng-Yen Tsai et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The role of SPARC in the TRAMP model of prostate carcinogenesis and progression

(2009) N Said et al.   ONCOGENE

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone

(2008) K. Chu et al.   MOLECULAR CANCER RESEARCH

Soluble EP2 neutralizes prostaglandin E2-induced cell signaling and inhibits osteolytic tumor growth

(2008) T. Takahashi et al.   MOLECULAR CANCER THERAPEUTICS